Skip to main content
. 2023 Jun 13;11:1164301. doi: 10.3389/fcell.2023.1164301

FIGURE 3.

FIGURE 3

Schematics showing pathways modulated by lncRNAs to induce EMT. (A) Interaction of TGF-β ligands with T-βR triggers the canonical TGF-pathway, leading to the formation of trimeric SMAD complexes (SMAD2–SMAD3–SMAD4) which act as transcription factors in the nucleus to regulate the expression of EMT-associated genes. lncRNAs, such as LINC00978 and TUG1, can modulate the TGF-β/SMAD signaling transduction by affecting the expression and phosphorylation of SMAD2/3 and SMAD4, respectively. (B) Interaction of Wnt ligands with frizzled receptors triggers the canonical Wnt pathway, leading to the release of β-catenin which binds with LEF and TCF to promote the expression of EMT-related genes. lncRNAs AFAP1-AS1 and HOTAIR modulate the Wnt/β-catenin pathway by affecting the phosphorylation of GSK3β and methylation of H3K27, respectively. (C) Interaction of Jagged/Delta-like ligands with Notch receptors triggers the canonical Notch pathway, leading to the generation of NICD which acts as a transcriptional co-activator in the nucleus. lncRNAs HNF1A-AS1 and UCA1 modulate the Notch pathway by regulating the expression of essential components and acting as ceRNA to regulate Notch signaling indirectly. (D) Growth factors activating the MEK-ERK and PI3K-AKT pathways also induce EMT through simultaneous activation of EMT-TFs. lncRNAs, such as UCA1 and HOXA-AS3, can act as ceRNA to regulate the expression of CREB1 and miR-29c, by promoting PIK3/AKT/mTOR pathway, and enhance the phosphorylation of MEK and ERK, respectively.